ACTG Publications

Factors associated with early study discontinuation in AACTG studies, DACS 200.Andersen, Janet W ; Fass, Robert ; van der Horst, Charles2007 SepContemp Clin Trials528
Safety and Immunogenicity of Zoster Vaccine Live in Human Immunodeficiency Virus-Infected Adults With CD4+ Cell Counts >200 Cells/mL Virologically Suppressed on Antiretroviral Therapy.Benson, Constance A ; Andersen, Janet W ; Macatangay, Bernard J C ; Mailliard, Robbie B ; Rinaldo, Charles R ; Read, Sarah ; Bozzolo, Dawn R ; Purdue, Lynette ; Jennings, Cheryl ; Keefer, Michael C ; Glesby, Marshall ; Tebas, Pablo ; Russell, Amy Falk ; Martin, Jason ; Annunziato, Paula ; Popmihajlov, Zoran ; Lennox, Jeffrey L2018 Nov 13Clin Infect Dis1167
Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 Study.Butt, Adeel A ; Umbleja, Triin ; Andersen, Janet W ; Sherman, Kenneth E ; Chung, Raymond T ; Actg A5178 Study Team2012 SepClin Infect Dis555
The effect of hepatitis C virologic clearance on cardiovascular disease biomarkers in human immunodeficiency virus/hepatitis C virus coinfection.Chew, Kara W ; Hua, Lei ; Bhattacharya, Debika ; Butt, Adeel A ; Bornfleth, Lorelei ; Chung, Raymond T ; Andersen, Janet W ; Currier, Judith S2014 DecOpen Forum Infect Dis31
Extended therapy with pegylated interferon and weight-based ribavirin for HCV-HIV coinfected patients.Chung, Raymond T ; Umbleja, Triin ; Chen, Jennifer Y ; Andersen, Janet W ; Butt, Adeel A ; Sherman, Kenneth E ; Actg A5178 Study Team2012 Mar-AprHIV Clin Trials213
Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: adherence analysis A5084.Cohn, Susan E ; Umbleja, Triin ; Mrus, Joseph ; Bardeguez, Arlene D ; Andersen, Janet W ; Chesney, Margaret A2008 JanAIDS Patient Care STDS122
Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy.Fife, Kenneth H ; Wu, Julia W ; Squires, Kathleen E ; Watts, D Heather ; Andersen, Janet W ; Brown, Darron R2009 Jul 1J Acquir Immune Defic Syndr351
Pharmacogenetics of nevirapine-associated hepatotoxicity: an Adult AIDS Clinical Trials Group collaboration.Haas, David W ; Bartlett, John A ; Andersen, Janet W ; Sanne, Ian ; Wilkinson, Grant R ; Hinkle, John ; Rousseau, Franck ; Ingram, Christiana D ; Shaw, Audrey ; Lederman, Michael M ; Kim, Richard B ; Adult AIDS Clinical Trials Group2006 Sep 15Clin Infect Dis643
Hepatitis C virus/HIV coinfection and responses to initial antiretroviral treatment.Hua, Lei ; Andersen, Janet W ; Daar, Eric S ; Glesby, Marshall J ; Hollabaugh, Kimberly ; Tierney, Camlin2013 Nov 13AIDS1727
A reduced frequency visit schedule underreports adverse events that resulted in dose modifications or treatment discontinuations in HIV/AIDS clinical trials: ACTG DACS 207.Kendall, Michelle A ; Andersen, Janet W ; van der Horst, Charles2006 JunContemp Clin Trials327
Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs.Luetkemeyer, Anne F ; Kendall, Michelle A ; Nyirenda, Mulinda ; Wu, Xingye ; Ive, Prudence ; Benson, Constance A ; Andersen, Janet W ; Swindells, Susan ; Sanne, Ian M ; Havlir, Diane V ; Kumwenda, Johnstone ; Adult AIDS Clinical Trials Group A5221 Study Team2014 Apr 1J Acquir Immune Defic Syndr465
Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention.Podany, Anthony T ; Bao, Yajing ; Swindells, Susan ; Chaisson, Richard E ; Andersen, Janet W ; Mwelase, Thando ; Supparatpinyo, Khuanchai ; Mohapi, Lerato ; Gupta, Amita ; Benson, Constance A ; Kim, Peter ; Fletcher, Courtney V ; AIDS Clinical Trials Group A5279 Study Team2015 Oct 15Clin Infect Dis861
Predictors of antiretroviral-related hepatotoxicity in the adult AIDS Clinical Trial Group (1989-1999).Servoss, Julie C ; Kitch, Douglas W ; Andersen, Janet W ; Reisler, Ronald B ; Chung, Raymond T ; Robbins, Gregory K2006 Nov 1J Acquir Immune Defic Syndr343
Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C).Sherman, Kenneth E ; Andersen, Janet W ; Butt, Adeel A ; Umbleja, Triin ; Alston, Beverly ; Koziel, Margaret J ; Peters, Marion G ; Sulkowski, Mark ; Goodman, Zachary D ; Chung, Raymond T ; AIDS Clinical Trials Group A5178 Study Team2010 Dec 15J Acquir Immune Defic Syndr555